Gene: ZNF506
Official Full Name: zinc finger protein 506provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Located in nucleolus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23542 | ZNF506 Knockout cell line (HEK293) | Human | ZNF506 | 1:3~1:6 | Negative | Online Inquiry |
ZNF506 Gene Knockout Cell Lines represent a pioneering advancement in the study of gene function and regulation within various biological contexts. These cell lines are specifically engineered to have the ZNF506 gene knocked out, allowing researchers to elucidate its role in cellular processes, gene expression, and potential disease mechanisms. By providing a controlled environment where the influence of the ZNF506 gene is completely removed, these cell lines serve as a critical tool for genetic and functional studies.
The primary mechanism of action involves the application of CRISPR-Cas9 technology, which facilitates precise genome editing. This approach enables the targeted disruption of the ZNF506 gene, resulting in a loss of function that can be analyzed across different experimental conditions. Researchers can then investigate the downstream effects on pathways associated with development, cellular differentiation, and pathogenesis, particularly in relation to conditions like cancer or genetic disorders.
From a scientific perspective, ZNF506 Gene Knockout Cell Lines are invaluable for advancing both basic and applied research. They contribute to the understanding of transcriptional regulation, as ZNF506 has been implicated in various signaling pathways and transcriptional networks. In clinical research, these cell lines can facilitate the development of novel therapeutic strategies aimed at modulating gene expression patterns linked to diseases.
What sets ZNF506 Gene Knockout Cell Lines apart from alternative products is their high specificity and efficiency, underpinned by rigorous validation processes. Each cell line undergoes comprehensive characterization to confirm the complete absence of ZNF506 expression at both the mRNA and protein levels. This guarantees that researchers are working with reliable and reproducible models that accurately reflect the biological implications of ZNF506 knockout.
Ultimately, ZNF506 Gene Knockout Cell Lines offer a crucial resource for researchers and clinicians alike, enabling them to probe the complexities of gene function and its contributions to disease. With a commitment to delivering cutting-edge genetic products, our company leverages extensive expertise in biotechnology to support innovative research and therapeutic development, ensuring that our customers have access to top-tier biological tools that drive scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.